Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.
Giacomelli R, Afeltra A, Bartoloni E, Berardicurti O, Bombardieri M, Bortoluzzi A, Carubbi F, Caso F, Cervera R, Ciccia F, Cipriani P, Coloma-Bazán E, Conti F, Costa L, D'Angelo S, Distler O, Feist E, Foulquier N, Gabini M, Gerber V, Gerli R, Grembiale RD, Guggino G, Hoxha A, Iagnocco A, Jordan S, Kahaleh B, Lauper K, Liakouli V, Lubrano E, Margiotta D, Naty S, Navarini L, Perosa F, Perricone C, Perricone R, Prete M, Pers JO, Pitzalis C, Priori R, Rivellese F, Ruffatti A, Ruscitti P, Scarpa R, Shoenfeld Y, Triolo G, Tzioufas A. Giacomelli R, et al. Among authors: coloma bazan e. Autoimmun Rev. 2021 Feb;20(2):102738. doi: 10.1016/j.autrev.2020.102738. Epub 2020 Dec 14. Autoimmun Rev. 2021. PMID: 33326854 Review.
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). Alijotas-Reig J, et al. Among authors: coloma bazan e. Autoimmun Rev. 2015 May;14(5):387-95. doi: 10.1016/j.autrev.2014.12.010. Epub 2014 Dec 31. Autoimmun Rev. 2015. PMID: 25555817 Review.
Cessation of oral anticoagulants in antiphospholipid syndrome.
Espinosa G, Coloma Bazán E, Cervera R. Espinosa G, et al. Among authors: coloma bazan e. Lupus. 2017 Oct;26(12):1347-1348. doi: 10.1177/0961203317707829. Epub 2017 May 3. Lupus. 2017. PMID: 28467292 No abstract available.
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre.
Barilaro G, Coloma-Bazan E, Chacur A, Della Rocca C, Perez-Isidro A, Ruiz-Ortiz E, Viñas O, Tàssies Penella D, Reverter JC, Molina Andujar A, Cervera R, Espinosa G. Barilaro G, et al. Among authors: coloma bazan e. Autoimmun Rev. 2022 Dec;21(12):103208. doi: 10.1016/j.autrev.2022.103208. Epub 2022 Oct 3. Autoimmun Rev. 2022. PMID: 36202304 Review.
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
Mostaza JM, Suárez-Fernández C, Cosín-Sales J, Gómez-Huelgas R, Brotons C, Araujo FP, Borrayo G, Ruiz E; VULCANO investigators. Mostaza JM, et al. BMC Cardiovasc Disord. 2022 Dec 22;22(1):560. doi: 10.1186/s12872-022-03013-w. BMC Cardiovasc Disord. 2022. PMID: 36550424 Free PMC article. Clinical Trial.